Close Menu

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that its first quarter revenues rose 7 percent year over year.

For the three months ended March 31, the firm said total revenues rose to $461.4 million from $431.7 million in the first quarter of 2018, beating analysts' consensus estimate of $450.1 million.

Bruker's organic revenue was up 6 percent year over year, while growth from acquisitions was 6 percent, and the negative effect from changes in foreign currency rates was 5 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.